Lateral epicondylitis: This is still a main indication for extracorporeal shockwave therapy.
S Thiele, R Thiele, L Gerdesmeyer
https://pubmed.ncbi.nlm.nih.gov/26455532Actively Recruiting
Phase Not Applicable
Age: 18Years - 75Years
All Genders
ID06438224
Clinical Utility of Extracorporeal Shock Wave Therapy in Restoring Hand Function of Patients With Nerve Injury and Hypertrophic Scars Due to Burns
Led by Hangang Sacred Heart Hospital · Updated on 2024-08-20
120
Participants Needed
1
Research Sites
5 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the effects of extracorporeal shock wave therapy (ESWT) on hand function in patients who have nerve injuries and hypertrophic scars caused by burns. Hand burns can lead to joint stiffness and muscle weakness that affect quality of life. This study compares ESWT to a sham treatment to explore its impact on nerve injury and scar tissue regeneration. Participants receive either ESWT or a sham treatment over 12 weeks, with one session per week. The ESWT is delivered using a specialized device targeting the most affected scar areas with 1000 to 3000 impulses per session at specific energy and frequency settings. The sham group receives a similar device that does not emit energy. During the study, researchers assess pain using a visual analog scale, hand function through several tests, grip strength, scar thickness, skin redness, water loss through the skin, and pigmentation. These measurements are taken before treatment and immediately after 12 weeks. The study involves randomized group assignment and double-blinding to ensure unbiased results.
CONDITIONS
Brief Title
Clinical Utility of ESWT in Restoring Hand Function of Patients With Nerve Injury and Hypertrophic Scars Due to Burns
Who Can Participate
Age: 18Years - 75Years
All Genders
Eligibility Criteria
You may qualify if you...
- 18 years or older
- Sustained a deep partial-thickness or full-thickness burn on the right dominant hand
- Burn treated with a split-thickness skin graft after injury
- Nerve injury to the hand confirmed by electromyography
- Burn injury occurred less than 6 months before enrollment
You will not qualify if you...
- Musculoskeletal diseases of the hands such as fractures, amputations, rheumatoid arthritis, or degenerative joint diseases
- Acute infection
- Malignant tumors
- Coagulopathy
- Pregnancy
- Risk of additional skin damage from ESWT and conventional occupational therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - 12 weeks
Participants receive extracorporeal shock wave therapy (ESWT) or sham stimulation targeting hypertrophic scars on the hand once a week.
12 weekly visits (in-person)
Trial Site Locations
Total: 1 location
1
Hangang sacred heart hodpital
Seoul, South Korea, 07247
Actively Recruiting
Loading map...
Research Team
S
Sung Rakyum
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Extracorporeal Shock Wave Therapy Alters the Expression of Fibrosis-Related Molecules in Fibroblast Derived from Human Hypertrophic Scar.
Hui Song Cui, A Ram Hong, June-Bum Kim...
https://pubmed.ncbi.nlm.nih.gov/29301325